Topical treatment strategies for non-melanoma skin cancer and precursor lesions

Seminars in Cutaneous Medicine and Surgery

Volumn 23, Issue 3, 2004, Pages 174-183

  McGillis, S Teri ^a   Fein, Howard ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; CELECOXIB; DEHYDROPYRIMIDINE DEHYDROGENASE; DICLOFENAC; ENZYME; FLUOROURACIL; HEMATOPORPHYRIN DERIVATIVE; IMIQUIMOD; NORDIHYDROGUAIARETIC ACID; PETROLATUM; PHOSPHATIDYLCHOLINE; PHOTOFRIN; UNCLASSIFIED DRUG;

ACTINIC KERATOSIS; ANTINEOPLASTIC ACTIVITY; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SURGERY; CARCINOGENESIS; CLINICAL TRIAL; CONTACT SENSITIVITY; CRYOSURGERY; DEHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY; DIARRHEA; DRUG CLEARANCE; DRUG CONTRAINDICATION; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG MECHANISM; DRUG PENETRATION; DRUG WITHDRAWAL; ENZYME DEFICIENCY; FOLLOW UP; HUMAN; NEUROTOXICITY; NEUTROPENIA; PAIN; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PRECANCER; REVIEW; SKIN ALLERGY; SKIN CANCER; SKIN EDEMA; SKIN IRRITATION; SKIN PENETRATION; STOMATITIS; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; AMINOQUINOLINES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; DICLOFENAC; FLUOROURACIL; HUMANS; KERATOSIS; PHOTOCHEMOTHERAPY; PRECANCEROUS CONDITIONS; SKIN NEOPLASMS; SUNLIGHT;

EID: 7644222585     PISSN: 10855629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sder.2004.06.005     Document Type: Review

References (63)

1. C.J. Cockerill Histopathology of incipient intarepidermal squamous cell carcinoma (actinic keratosis) J Am Acad Dermatol 42 2000 S11 S17
2. K.J. Ashton, S.R. Weinstein, D.J. Maguire, L.R. Griffiths Chromosomal aberrations in squamous cell carcinoma and solar keratosis revealed by genomic hybridization Arch Dermatol 139 7 2003 876 882
3. N.M. Wikonkal, D.E. Brash Ultraviolet radiation induced signature mutations in photocarcinogenesis J Investig Dermatol Symp Proc 4 1 1999 6 10
4. D.E. Brash, A. Zeigler, A.S. Jonason, J.A. Simon, S. Kunala, D.J. Leffell Sunlight and sunburn in human skin p53, apoptosis and tumor promotion J Investig Dermatol Symp Proc 19 2 1996 136 142
5. A. Stanimirovic, H. Cupic, B. Bosnjak, B. Kruslin, A. Belicza Expression of p53, bcl-2 and growth hormone receptor in actinic keratosis, hypertrophic type Arch Dermatol Res 295 3 2003 102 108
6. M.A. Mittelbronn, D.L. Mullins, P.A. Ramos-Caro, F.P. Flowers Frequency of pre existing actinic keratosis in squamous cell carcinoma Int J Dermatol 37 1998 677 681
7. D. English, B. Armstrong, A. Kricker, M.G. Winter, P.J. Heenan, P.L. Randall Demographic characteristics, pigmentary and cutaneous risk factors for squamous cell carcinoma of the skin a case control study Int J Cancer 76 5 1998 628 634
8. R. Marks, G. Rennie, T. Selwood The relationship of basal and squamous cell carcinomas to solar keratoses Arch Dermatol 124 7 1988 1039 1042
9. L.H. Goldberg, J.R. Chang, S.C. Bauer, J.D. Schmidt Proliferative actinic keratosis three representative cases J Dermatol Surg 26 1 2000 65 69
10. S.R. Feldman, A.B. Fleischer Jr, P.M. Williford, J.L. Jorizzo Destructive procedures are the standard of care for the treatment of actinic keratoses J AM Acad Dermatol 40 1 1999 43 47
11. E. Epstein Does intermittent pulse topical 5-fluorouracil therapy allow destruction of actinic keratoses without significant inflammation? J Acad Dermatol 38 1998 77 80
12. D.L. Pearlman Weekly pulse dosing effective and comfortable topical 5-fluorouracil treatment of multiple facial actinic keratoses J Am Acad Dermatol 25 1991 665 667
13. G.M. Marrero, B.E. Katz The new fluor-hydroxy peel. A combination of 5-fluorouracil and glycolic acid Dermatol Surg 24 9 1998 973 978
14. K. Loven, L. Stein, K. Furst, S. Levy Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis Clin Ther 24 6 2002 990 1000
15. M.L. Welch, W.J. Grabski, M.L. McCollough, H.G. Skelton, K.J. Smith, Menon 5-fluorouracil iontophoretic therapy for Bowen's disease J Am Acad Dermatol 36 6 1997 956 958
16. H. Bargman, J. Hochman Topical treatment of Bowen's disease with 5-florouracil J Cutan Med Surg 7 2 2003 101 105
17. R. Romadgosa, L. Saap, M. Givens, A. Salverroy, J.L. He, S.L. Hsia A pilot study to evaluate the treatment of basal cell carcinoma with 5-fluorouracil using phosphatidyl choline as a trans-epidermal carrier Dermatol Surg 26 4 2003 338 340
18. S.Y. Buckman, A. Gresham, P. Hale, G. Hruza, J. Anast, J. Masferrer COX-2 expression is induced by UVB exposure in human skin implications for the development of skin cancer Carcinogenesis 19 5 1998 723 729
19. I. Arany, S.K. Tyring, M.M. Brysk, M.A. Stanley, M.A. Tomai, R.L. Miller Correlation between pretreatment levels of interferon response genes and clinical responses to an immune immune response modifier (Imiquimod) in genital warts Antimicrob Agents Chemother 44 7 2000 1869 1873
20. S.J. Salasche, N. Levine, L. Morrison Cycle therapy of actinic keratoses of the face and scalp with 5% topical Imiquimod cream an open label trial J Am Acad Dermatol 47 4 2002 571 577
21. M.K. Kagy, R. Amonette The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient Dermatol Surg. 26 2000 577 578
22. K.R. Beutner, J.K. Geisse, D. Helman, T.L. Fox, A. Ginkel, M.L. Owens Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream J Am Acad Dermatol. 41 1999 1002 1007
23. T.L. Schroeder, R.D. Sengelmann Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream J Am Acad Dermatol 46 2002 545 548
24. K. Chen, S. Shumack Treatment of Bowen's disease using a cycle regimen of imiquimod 5% cream Clin Exp Dermatol 28S 2003 10 12
25. E. Nagore, A. Sevila, O. Sanmartin, R. Botella-Estrada, C. Requena, C. Serra-Guillen, P. Sanchez-Pedreno, C. Guillen Excellent response of basal cell carcinomas and pigmentary changes in xeroderma pigmentosum to imiquimod 5% cream Br J Dermatol 149 2003 858 861
26. S. Shumack, J. Robinson, S. Kossard, L. Golitz, H. Greenway, A. Schroeter, K. Andres, M. Amies, M. Owens Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma comparison of dosing regimens Arch Dermatol 138 2002 1165 1171
27. A. Huber, J.D. Huber, R.B. Skinner, R.T. Kuwahara, R. Haque, R.A. Amonette Topical imiquimod treatment for nodular Basal cell carcinomas an open-label series Dermatol Surg 30 2004 429 430
28. A. Mackenzie-Wood, S. Kossard, J. de Launey, B. Wilkinson, M.L. Owens Imiquimod 5% cream in the treatment of Bowen's disease J Am Acad Dermatol 44 2001 462 470
29. K.J. Smith, M. Germain, H.G. Skelton Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy Dermatol Surg 27 6 2001 5611 5614
30. J. Moan, Q. Peng An outline of the hundred-year history of PDT Anticancer Res 23 2003 3591 3600
31. J.G. Levy Photosensitizers in photodynamic therapy Semin Oncol. 6 1994 4 10
32. R.M. Szeimies, M. Landthaler Photodynamic therapy and fluorescence diagnosis of skin cancers Recent Results Cancer Res 160 2002 240 245
33. A.F. Taub Photodynamic therapy in dermatology history and horizons J Drugs Dermatol 3 2004 S8 S25
34. von Tappeiner H, Jesionek A: Therapeutische Verusche mit fluorescierenden Stoffen. Munch Med Wochenschr 47:2043-2044
35. T.J. Dougherty Photosensitization of malignant tumors Semin Surg Oncol 2 1986 24 37
36. T.J. Dougherty, J.E. Kaufman, A. Goldfarb, K.R. Weishaupt, D. Boyle, A. Mittleman Photoradiation therapy for the treatment of malignant tumors Cancer Res. 38 1978 2628 2635
37. H. Liu Photodynamic therapy in dermatology with porfimer sodium and benzoporphyrin derivative an update Semin Oncol 6 1994 11 14
38. Axcan Pharama Inc Website: http://www.scandipharm.com/en-us/ photofrin_faq.aspx?lang=en-us&m=120&n=4#676. Accessed on February 29, 2004
39. V.G. Schweitzer PHOTOFRI. N-mediated photodynamic therapy for treatment of early stage oral cavity and laryngeal malignancies Lasers Surg Med 29 4 2001 305 313
40. B.D. Wilson, T.S. Mang, H. Stoll, C. Jones, M. Cooper, T.J. Dougherty Photodynamic therapy for the treatment of basal cell carcinoma Arch Dermatol 128 1992 1597 1601
41. R.R. Allison, T.S. Mang, B.D. Wilson Photodynamic therapy for the treatment of nonmelanomatous cutaneous malignancies Semin Cutan Med Surg 17 1998 153 163 (Jun)
42. V.G. Schweitzer Photofrin-mediated photodynamic therapy for treatment of aggressive head and neck nonmelanomatous skin tumors in elderly patients Laryngoscope 111 2001 1091 1098
43. J.C. Kennedy, R.H. Pottier, D.C. Pross Photodynamic therapy with endogenous protoporphyrin IX basic principles and present clinical experience J Photochem Photobiol B 6 1990 143 148
44. S.L. Ratcliffe, E.K. Matthews Modification of the photodynamic action of delta-aminolaevulinic acid (ALA) on rat pancreatoma cells by mitochondrial benzodiazepine receptor ligands Br J Cancer 71 1995 300 305
45. J.C. Tsai, I.H. Chen, T.W. Wong, Y.L. Lo In vitro/in vivo correlations between transdermal delivery of 5-aminolaevulinic acid and cutaneous protoporphyrin IX accumulation and effect of formulation Br J Dermatol 146 2002 853 862
46. A.F. Taub Photodynamic therapy in dermatology history and horizons J Drugs Dermatol 3 2004 S8 25
47. P.G. Calzavara-Pinton Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours J Photochem Photobiol B 29 1995 53 57
48. R. Fink-Puches, A. Hofer, J. Smolle, H. Kerl, P. Wolf Primary clinical response and long-term follow-up of solar keratoses treated with topically applied 5-aminolevulinic acid and irradiation by different wave bands of light J Photochem Photobiol B 41 1997 145 151
49. E.W. Jeffes, J.L. McCullough, G.D. Weinstein, P.E. Fergin, J.S. Nelson, T.F. Shull, K.R. Simpson, L.M. Bukaty, W.L. Hoffman, N.L. Fong Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study Arch Dermatol 133 1997 727 732
50. E.W. Jeffes, J.L. McCullough, G.D. Weinstein, R. Kaplan, S.D. Glazer, J.R. Taylor Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light J Am Acad Dermatol. 45 2001 96 104
51. D.J. Piacquadio, D.M. Chen, H.F. Farber, J.F. Fowler Jr, S.D. Glazer, J.J. Goodman, L.L. Hruza, E.W. Jeffes, M.R. Ling, T.J. Phillips, T.M. Rallis, R.K. Scher, C.R. Taylor, G.D. Weinstein Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp investigator-blinded, phase 3, multicenter trials Arch Dermatol 140 2004 41 46 (Jan)
52. D. Touma, M. Yaar, S. Whitehead, N. Konnikov, B.A. Gilchrest A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage Arch Dermatol 140 1 2004 33 40
53. M.R. Alexiades-Armenakas, R.G. Geronemus Laser-mediated photodynamic therapy of actinic keratoses Arch Dermatol 139 2003 1313 1320
54. R. Ruiz-Rodriguez, T. Sanz-Sanchez, S. Cordoba Photodynamic photorejuvenation Dermatol Surg 28 2002 742 744
55. F. Cairnduff, M.R. Stringer, E.J. Hudson, D.V. Ash, S.B. Brown Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer Br J Cancer 69 1994 605 608
56. A.M. Wennberg, L.E. Lindholm, M. Alpsten, O. Larko Treatment of superficial basal cell carcinomas using topically applied delta-aminolaevulinic acid and a filtered xenon lamp Arch Dermatol Res 288 1996 561 564
57. A.M. Soler, E. Angell-Petersen, T. Warloe, J. Tausjo, H.B. Steen, J. Moan, K.E. Giercksky Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid a comparison of two light sources Photochem Photobiol 71 2000 724 729 (Jun)
58. C.A. Morton, C. Whitehurst, J.H. McColl, J.V. Moore, R.M. MacKie Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma Arch Dermatol 137 2001 319 324 (Mar)
59. E.S. Marmur, C.D. Schmults, D.J. Goldberg A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer Dermatol Surg 30 Suppl. 2 2004 264 271
60. FDA.gov website. Retrieved on March 13, 2004. http://www.fda.gov/ohrms/ dockets/ac/03/slides/1
61. Photocure.com website. Retrieved on March 13, 2004. http://www.photocure. com/
62. S. Smith, D. Piacquadio, V. Morhenn, D. Atkin, R. Fitzpatrick Short incubation PDT versus 5-FU in treating actinic keratoses J Drugs Dermatol 2 2003 629 635
63. J.K. Geisse, P. Rich, A. Pandya, K. Gross, K. Andres, A. Ginkel, M. Owens Imiquimod 5% cream for the treatment of superficial basal cell carcinoma a double-blind, randomized, vehicle-controlled study J Am Acad Dermatol 47 2002 390 398